Ligne de temps

Benjamin Vesin
Technicien(ne)
04 juil. 2025
publication

Optimized lentiviral backbone induces robust and diverse T cell immunity against neoantigens to counteract tumor heterogeneity.

Lire plus
09 déc. 2024
publication

Enhanced hepatitis B virus-specific immunity by combining neutralizing antibody therapy and DNA vaccination in a murine model of chronic hepatitis B virus infection.

Lire plus
10 juin 2024
publication

T-cell immunity induced and reshaped by an anti-HPV immuno-oncotherapeutic lentiviral vector.

Lire plus
07 sept. 2023
publication

Full eradication of pre-clinical human papilloma virus-induced tumors by a lentiviral vaccine.

Lire plus
21 déc. 2022
publication

Full-Lung Prophylaxis against SARS-CoV-2 by One-Shot or Booster Intranasal Lentiviral Vaccination in Syrian Golden Hamsters

Lire plus
29 juil. 2021
team

Laboratoire Commun Pasteur – TheraVectys

Lire plus